Beta cells and the future of diabetes care feature. Cell dedifferentiation in human type 2 diabetes article pdf available in the journal of clinical endocrinology and metabolism 1014. Strikingly, we identify the same sequence of events as a feature of different models of murine diabetes. Cell lineagetracing in rodents and human autopsy surveys support the notion of. Request pdf on feb 7, 20, yuval dor and others published betacell dedifferentiation and type 2 diabetes find, read and cite all the research you need. Beta cell dedifferentiation in type 2 diabetes jdrf npod. New data provide support for betacell dedifferentiation as a cause of reduced insulin secretion. Astwood award lecture by recipient domenico accili, md, on the dedifferentiation, rather than the death, of pancreatic. As betacell function progressively declines over time, blood glucose rises. Gradual accumulation of fat in the liver and pancreas leads eventually to beta cell dedifferentiation and loss of specialised function. It has been suggested that beta cell failure in t2d involves massive cell death.
The conference featured prominent discussions surrounding beta cells in type 2 diabetes, notably the michaela diamant memorial symposium on beta cell failure in type 2 diabetes, chaired by kenneth polonsky, md, and the edwin b. Prior attempts at beta cell regeneration have relied upon pancreatic injury to induce beta cell proliferation, dedifferentiation and. Both classic forms of diabetes mellitus are characterized by the inability of pancreatic. Moreover, type 2 diabetes is a heterogeneous disease, and it is plausible that there are other groups of patients perhaps lean patients, as opposed to the obese patients reported here in which.
Cell dedifferentiation, however, is a broad and loosely defined term that generally refers to an alteration in. This process is reversible, such that the same cell can regain an insulinpositive. Other studies ascribe beta cell failure to cell exhaustion, due to chronic oxidative or endoplasmic reticulum stress leading to cellular dysfunction. Betacell dedifferentiation and type 2 diabetes article in new england journal of medicine 3686. Research design and methods a group of experts participated in a conference on 1416 october 20 cosponsored by the endocrine society and the american diabetes.
Inappropriately increased alphacell function importantly contributes to hyperglycemia and reflects the loss of tonic restraint normally exerted by high. We scored dedifferentiation using markers of endocrine lineage. Cell maturation and identity in health and disease mdpi. Betacell dedifferentiation in type 2 diabetes stem. Alterations in beta cell identity in type 1 and type 2. A decrease in the number of functional insulinproducing. Although a few fdaapproved therapies for type 2 diabetes meglitinides, sulfonylureas, incretinbased drugs directly enhance betacell function, no therapies for any form of diabetes.
Modeling human pancreatic beta cell dedifferentiation. Targeting betacell preservation in the management of type 2 diabetes type 2 diabetes t2d is widely considered a chronic and progressive disease without cure. Beta cell failure is a central feature of type 2 diabetes t2d, but the molecular underpinnings of the process remain only partly understood. We propose that dedifferentiation trumps endocrine cell death in the natural history of. Beta cell formation in vivo through cellular networking. The role of glucagon on type 2 diabetes at a glance. Betacell failure in type 2diabetes type 2 diabetes t2d, which accounts for the vast majority of diabetes cases, is one of the greatest global health problems. Here, we examined the sensitivity of key isletenriched transcription factors to oxidative stress, a condition associated with.
The opposite effects of insulin and glucagon in fuel homeostasis, the paracrineendocrine inhibitory effects of insulin on glucagon secretion and the hyperglucagonemia in the pathogenesis of type 2 diabetes t2d have long been recognized. Type 1, type 2, lada or since onfusion abounds, isnt it time for a new classification schema for the diagnosis and treatment of diabetes mellitus dm get us ready for preision mediine. Type 2 diabetes mellitus t2dm is believed to be associated with lowgrade chronic inflammation. In type 2 diabetes, the body becomes resistant to its insulin and attempts to compensate by producing a higher quantity of insulin. The reversible nature of early type 2 diabetes has been demonstrated in in vivo human studies. Type 2 diabetes t2d, which accounts for the vast majority of diabetes cases, is one of the greatest global health problems. Although it is well established that type 2 diabetes t2d is generally due to the progressive loss of. Alterations in beta cell identity in type 1 and type 2 diabetes. Type 2 diabetes results from a combination of insulin resistance and dysfunction of insulin producing pancreatic beta cells. Targeting betacell preservation in the management of type. The current study aims to investigate the involvement of leptin and tnf.
Currently it affects 9% of world population, and its prevalence is increasing in epidemic proportions 1. Evidence of betacell dedifferentiation in human type 2 diabetes. Intriguingly, fgf1 levels are elevated in newly diagnosed cases of type 2 diabetes as compared to normal glucose tolerance controls. Betacell failure in type 2 diabetes t2d was recently proposed to involve dedifferentiation of betacells and ectopic expression of other islet hormones, including somatostatin and glucagon. Pancreatic beta cell dedifferentiation as a mechanism of. Starting with a hypothesis which postulated a simple explanation arising from the basic cause of type 2 diabetes, a series of studies has introduced a paradigm shift in our understanding of the condition. Opinions diverge regarding the relative contribution of a decrease in. Themetabolicstressof chronic nutrient oversupply can lead to reduced expression or nuclear activity ofkey bcell tran. The objective of the study was to establish the potential impact of. We arbitrarily defined a dedifferentiated cell as a synpositive ie, endocrine cell that failed to react with antibodies to the 5 pancreatic hormones.
Genetic predisposition for beta cell fragility underlies. Pancreatic beta cell write as beta cell, hereafter plays a central role in regulating glucose. This includes the loss of transcriptional regulators of beta cell function as well as other critical components of beta cell function. They find that the changes in the molecular pathways identified as contributing to beta cell loss are paralleled in human islets from patients with type 2 diabetes. Betacell dedifferentiation and type 2 diabetes request pdf. Research has shown that chronically elevated blood glucose levels chronic hyperglycemia over a long period of time can lead to beta cells wearing out, referred to as beta cell. Type 2 diabetes t2d is caused by an inherited predisposition to pancreatic.
Beta cell mass is a simple concept, it is just the weight of all of the. Type 2 diabetes mellitus t2d is characterized by insulin resistance in tissues including the liver, skeletal muscle and adipose tissue, and by impaired pancreatic beta cell function 1. To determine whether similar processes occur in human type 2 diabetes, we surveyed pancreatic. Disclosure forms provided by the authors are available with the full text of this article at nejm. Although several studies have highlighted evidence from rodent models, 75 cell dedifferentiation is also proposed to be a feature in the pathophysiology of human type 2 diabetes. We assessed dedifferentiation in pancreata from organ donors with and without diabetes. By these criteria, dedifferentiated cells accounted for 31. Diabetes epigenetics gene expression pancreatic differentiation abstract type 2 diabetes t2d is caused by an inherited predisposition to pancreatic islet.
Betacell dedifferentiation and type 2 diabetes nejm. This concept is termed dedifferentiation and has been proposed, besides cell death, as a contributing factor to the loss of functional. Metabolic stress and compromised identity of pancreatic. Type 2 diabetes mellitus t2dm, which constitutes more than 90 % of the diabetes patients, is generally linked with insulin resistance of peripheral tissue, reduction of beta cell mass and compromised insulin secretion ability of beta cells 1, 2. Preventing beta cell dedifferentiation in type 1 diabetes. In a similar study using insulinresistant rodents, betatrophin was found to. We intend to investigate whether humans with type 1 and 2 diabetes develop the same abnormalities observed in foxo1. Pancreatic beta cell dedifferentiation as a mechanism of diabetic beta cell failure. Type 2 diabetes is associated with defective insulin secretion, reduced. Recent evidence suggests that beta cell dedifferentiation is a key early mechanism that underlies the pathogenesis of type 2 diabetes t2d 1. Insulin replacement therapy is essential in type 1 diabetic individuals and is required in 40 50% of type 2 diabetics during their lifetime. Evidence for loss in identity, dedifferentiation, and transdifferentiation of islet. Effect of the sodiumglucose cotransporter 2 inhibitor. Normal betacell function the main role of betacell is to synthesize and secrete insulin in order to maintain circulating glucose levels within physiological range.
We thus hypothesize that an excess pancreatic fgf can contribute to. Calorie restriction for longterm remission of type 2 diabetes. Betacell dedifferentiation and type 2 diabetes new england. Cell failure in type 2 diabetes type 2 diabetes t2d, which accounts for the vast majority of diabetes cases, is one of the greatest global health problems. Type 2 diabetes is caused by enhanced insulin resistance and reduced insulin secretion. Cell deficit in obese type 2 diabetes, a minor role of.
833 927 1052 286 724 475 1034 78 823 860 402 1049 473 902 696 1560 77 1232 988 1359 379 761 44 558 786 119 826 1325 1366 973 99 752 196 287 1166 620 665 569 628 1253 97 1188 816 1464 1180